CurrentBlue Cross Blue Shield - TexasPolicy CPCPLAB010

Vitamin B12 and Methylmalonic Acid Testing

This policy governs reimbursement criteria for serum vitamin B12 (cobalamin) and methylmalonic acid testing for Blue Cross Blue Shield of Texas members and applies to providers submitting claims under BCBSTX plan documents.

Policy Summary

PayerBlue Cross Blue Shield - Texas

PolicyVitamin B12 and Methylmalonic Acid Testing

Policy CodePolicy CPCPLAB010

Change TypeMaterial and organizational updates (frequency limit addedexclusions clarified)

Effective DateMay 15, 2025

Next Review Date

Key ActionSubmit accurate documentation; providers may be asked to provide additional documentation upon request and claims are subject to claim review and code edit protocols.

SourceLink

POLICY UPDATE CHANGES

A three-month testing frequency limit was added: total vitamin B12 (serum cobalamin) testing may be reimbursable once every three months for specified situations.

Holotranscobalamin testing is not reimbursable for screening, testing, or confirmation of vitamin B12 deficiency.

A catch-all noncoverage statement: for all other situations not described above, total vitamin B12 (serum cobalamin) testing is not reimbursable.

Reimbursement Information was reorganized so former statements are included under the new three-month frequency main criterion.

1x/3momax reimb. frequency (B12)

not reimb.holotranscobalamin

not reimb.homocysteine

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria for Vitamin B12 and Methylmalonic Acid Testing

Coverage criteria for B12 and methylmalonic acid testing

Total vitamin B12 (serum cobalamin) testing may be reimbursable once every three months when the criteria below are met; methylmalonic acid testing may be reimbursable in specified situations.

ALL of the following

Signs or symptoms consistent with B12 deficiency
- Cutaneous: hyperpigmentation, jaundice, vitiligo.
- Gastrointestinal: glossitis.
- Hematologic: anemia (macrocytic, megaloblastic), leukopenia, pancytopenia, thrombocytopenia, thrombocytosis.
- Neuropsychiatric: areflexia; cognitive impairment (including dementia-like symptoms and acute psychosis); gait abnormalities; irritability; loss of proprioception and vibratory sense; olfactory impairment; peripheral neuropathy.
Individuals undergoing treatment for vitamin B12 deficiency.
Presence of one or more risk factors
- Decreased ileal absorption: Crohn's disease; ileal resection; tapeworm infection; prior or scheduled bariatric procedures (e.g., Roux-en-Y gastric bypass, sleeve gastrectomy, biliopancreatic diversion/duodenal switch).
- Decreased intrinsic factor: atrophic gastritis; pernicious anemia; postgastrectomy syndrome.
- Transcobalamin II deficiency.
- Inadequate intake: alcohol abuse; age >75 years or elderly individuals evaluated for dementia; vegans or strict vegetarians (including exclusively breastfed infants of vegetarian/vegan mothers); eating disorder.
- Prolonged medication use: H2 blocker use >12 months; metformin use >4 months; proton pump inhibitor use >12 months.

Methylmalonic acid testing reimbursable

Asymptomatic high-risk individuals with low-normal vitamin B12 or when vitamin B12 deficiency is suspected but serum vitamin B12 is normal or low-normal (methylmalonic acid to confirm deficiency).
For the evaluation of inborn errors of metabolism (methylmalonic acid testing).

Not reimbursable

Screening for vitamin B12 deficiency in healthy, asymptomatic individuals is not reimbursable.
Homocysteine testing is not reimbursable for confirmation of vitamin B12 deficiency.
Holotranscobalamin testing is not reimbursable for screening, testing, or confirmation of vitamin B12 deficiency.
For all other situations not described above, total vitamin B12 (serum cobalamin) testing is not reimbursable.

Procedure Coding and Frequency

Procedure coding notemixed

Procedure codes listed but not exhaustive; inclusion does not guarantee coverage.

Testing frequency threshold

Maximum reimbursable frequencyTotal vitamin B12 (serum cobalamin) testing reimbursable once every three months

Applicable situationsReimbursable once every three months when criteria such as signs/symptoms, undergoing treatment, or listed risk factors are met

Noncovered scenariosFor all other situations not described in criteria, total vitamin B12 testing is not reimbursable

Documentation and Claims Review Requirements

Documentation Required

Documentation and Claims Review Requirement

Providers are responsible for submitting accurate documentation of services performed and must code and bill using valid HIPAA-approved code sets and industry-standard coding guidelines (e.g., UB, AMA/CPT, CPT Assistant, HCPCS, ICD-10-CM/PCS, NDCs, DRG, CMS NCCI policy/manual and table edits). Claims are subject to code-edit protocols and review for benefit coverage, provider contract terms, medical policies, clinical payment and coding policies, and coding software logic. Upon request, providers must submit additional supporting documentation. If a conflict exists between this Clinical Payment and Coding Policy and any plan document or participating provider contract, the plan document or provider contract governs as applicable; BCBSTX retains discretion in interpreting and applying this policy.

Submit claims using valid HIPAA-approved code sets and industry coding guidelines (CPT, HCPCS, ICD-10, NDC, DRG, CMS/NCCI, etc.).
Claims are subject to code-edit protocols and may be reviewed against benefit coverage, provider contract language, medical policies, CPCPs, and coding software logic.
Providers may be asked to provide additional documentation — submit promptly upon request to support medical necessity and correct coding.
If a conflict exists between this CPCP and a plan document or provider contract, the plan document or provider contract governs; BCBSTX retains discretionary authority for interpretation and application.

Definitions

Total vitamin B12 testing (definition)

Test nameTotal vitamin B12 (serum cobalamin)

Common specimenSerum

PurposeAssessment of vitamin B12 status when clinical signs/symptoms, treatment monitoring, or risk factors are present

Coverage noteMay be reimbursable once every three months when criteria are met; screening in healthy asymptomatic individuals is not reimbursable

Methylmalonic acid testing (definition/notes)

When reimbursableMethylmalonic acid testing may be reimbursable to confirm vitamin B12 deficiency in asymptomatic high-risk individuals with low-normal B12 or when deficiency is suspected despite normal/low-normal serum B12